Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CALCIUM CARBONATE CHOLECALCIFEROL CONCENTRATE
Pfizer Consumer Healthcare Ltd
600/400
Film Coated Tablet
2009-04-24
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Caltrate 600 mg/400 IU, Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: 600 mg of calcium (as calcium carbonate) 10 micrograms of cholecalciferol (equivalent to 400 I.U. vitamin D 3 ) Excipients: sucrose, partially hydrogenated soya bean oil. For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Capsule-shaped grey/beige tablets. One side is scored and engraved with “D” on the left and “600” on the right of the score. The other side is engraved with “Caltrate”. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Correction of combined vitamin D and calcium deficiencies in the elderly. Supply of vitamin D and calcium as an adjunct to specific treatments for osteoporosis, in patients where combined vitamin D and calcium deficiencies have been diagnosed or those at high risk of such deficiency. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS AND ELDERLY One tablet twice a day (e.g. one tablet in the morning and one tablet in the evening). Dose reduction should be considered as necessary following the monitoring of calcium levels as indicated in section 4.4 and 4.5. PREGNANT WOMEN One tablet a day (see section 4.6). POSOLOGY IN CASES OF HEPATIC INSUFFICIENCY The dose does not require adjustment. The tablet should be swallowed with a large glass of water. 4.3 CONTRAINDICATIONS • Hypersensitivity to one of the active substances or to one of the excipients. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 26/08/2011_ _CRN 2092766_ _page numb Read the complete document